Gut microbiota dysbiosis has been repeatedly observed in obesity and type 2 diabetes
mellitus, two metabolic diseases strongly intertwined with non-alcoholic fatty liver disease …

The Christensenellaceae, a recently described family in the phylum Firmicutes, is emerging
as an important player in human health. The relative abundance of Christensenellaceae in …

Background Immune-mediated inflammatory disease (IMID) represents a substantial health
concern. It is widely recognized that IMID patients are at a higher risk for developing …

Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, is a
complex disorder with an unknown cause. However, the dysbiosis of the gut microbiome has …

Proteus species, members of the Enterobacteriaceae family, are usually considered
commensals in the gut and are most commonly recognized clinically as a cause of urinary …

Background & Aims Proteus spp, Gram-negative facultative anaerobic bacilli, have recently
been associated with Crohn's disease (CD) recurrence after intestinal resection. We …

Introduction: Inflammatory bowel diseases (IBD) are on the rise worldwide. This review
covers the current concepts of the etiology of Crohn´ s disease and ulcerative colitis by …

Spondyloarthritis (SpA) encompasses a heterogeneous group of chronic inflammatory
diseases that can affect both axial and peripheral joints, tendons and entheses. Among the …

Background The gastrointestinal microbiota is the key antigenic drive in the inflammatory
bowel diseases. Randomized controlled trials (RCTs) in ulcerative colitis have established …

The gut microbiome has increasingly been recognized as a critical and central factor in
inflammatory bowel disease (IBD). Here, we review specific microorganisms that have been …